EFFICACY OF RUXOLITINIB IN MYELOID NEOPLASMS WITH PCM1-JAK2 FUSION GENE

被引：0
|
作者：
Casetti, I. C. [1 ]
Milosevic, J. D. [2 ]
Rumi, E. [3 ]
Selleslag, D. [4 ]
Lierman, E. [5 ]
Pietra, D. [3 ]
Cavalloni, C. [1 ]
Bellini, M. [1 ]
Milanesi, C. [3 ]
Astori, C. [3 ]
Kralovics, R. [2 ]
Vandenberghe, P. [5 ]
Cazzola, M. [1 ,3 ]
机构：
[1] IRCCS Policlin San Matteo, Dept Mol Med, Pavia, Italy
[2] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria
[3] IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy
[4] Acad Hosp St Jan, Dept Hematol, Brugge, Belgium
[5] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1342
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [11] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Verena Patterer
    Susanne Schnittger
    Wolfgang Kern
    Torsten Haferlach
    Claudia Haferlach
    Annals of Hematology, 2013, 92 : 759 - 769
  • [12] Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?
    Bain, Barbara J.
    Ahmad, Shahzaib
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (06) : 809 - 817
  • [13] Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes
    Schwaab, Juliana
    Naumann, Nicole
    Luebke, Johannes
    Jawhar, Mohamad
    Somervaille, Tim C. P.
    Williams, Mark S.
    Frewin, Rebecca
    Jost, Philipp J.
    Lichtenegger, Felix S.
    La Rosee, Paul
    Storch, Nicola
    Haferlach, Torsten
    Horny, Hans-Peter
    Fabarius, Alice
    Haferlach, Claudia
    Burchert, Andreas
    Hofmann, Wolf-Karsten
    Cross, Nicholas C. P.
    Hochhaus, Andreas
    Reiter, Andreas
    Metzgeroth, Georgia
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (07) : 824 - 833
  • [14] Efficacy of Ruxolitinib in Chronic Eosinophilic Leukemia Associated with t(8;9)(p22;p24) and PCM1-JAK2 Fusion Gene
    Casetti, Ilaria
    Rumi, Elisa
    Milosevic, Jelena D.
    Dambruoso, Irene
    Pietra, Daniela
    Boveri, Emanuela
    Boni, Marina
    Bernasconi, Paolo
    Passamonti, Francesco
    Kralovics, Robert
    Cazzola, Mario
    BLOOD, 2012, 120 (21)
  • [15] Clinicopathologic Study of Myeloid/Lymphoid Neoplasms with Altered PDGFRA, PGDFRB, FGFR1 and PCM1-JAK2
    Aqil, Barina
    Sukhanova, Madina
    Jennings, Lawrence
    Lu, Xinyan
    Chen, Yi-Hua
    Gao, Juehua
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 804 - 805
  • [16] Clinicopathologic Study of Myeloid/Lymphoid Neoplasms with Altered PDGFRA, PGDFRB, FGFR1 and PCM1-JAK2
    Aqil, Barina
    Sukhanova, Madina
    Jennings, Lawrence
    Lu, Xinyan
    Chen, Yi-Hua
    Gao, Juehua
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 804 - 805
  • [17] Two Cases of Mycosis Fungoides With PCM1-JAK2 Fusion
    Fernandez-Pol, Sebastian
    Neishaboori, Nastaran
    Chapman, Courtney M.
    Khodadoust, Michael S.
    Kim, Youn H.
    Rieger, Kerri E.
    Suarez, Carlos J.
    JCO PRECISION ONCOLOGY, 2021, 5 : 646 - 652
  • [18] Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
    Pozdnyakova, Olga
    Orazi, Attilio
    Kelemen, Katalin
    King, Rebecca
    Reichard, Kaaren K.
    Craig, Fiona E.
    Quintanilla-Martinez, Leticia
    Rimsza, Lisa
    George, Tracy, I
    Horny, Hans-Peter
    Wang, Sa A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (02) : 160 - 178
  • [19] Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2
    Luedke, Catherine
    Rein, Lindsay
    BLOOD, 2020, 136 (09) : 1113 - 1113
  • [20] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
    Romagnoli, Simone
    Bartalucci, Niccolo
    Gesullo, Francesca
    Balliu, Manjola
    Bonifacio, Stefania
    Fernandez, Anair Graciela Lema
    Mannelli, Francesco
    Bolognini, Davide
    Pelo, Elisabetta
    Mecucci, Cristina
    Guglielmelli, Paola
    Vannucchi, Alessandro Maria
    BIOMARKER RESEARCH, 2021, 9 (01)
12345